Wilmington, NC – The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has earned numerous recognitions, including the highest honor of “Clinical Research Company of the Year,” at the 2022 PharmaTimes Clinical Researcher of the Year-The Americas competition, which recognizes top talent in the clinical research industry.
More than 20 PPD clinical researchers also received honors in the team and individual categories of the competition. The wins reinforce the business’ commitment to recruiting the highest caliber of clinical research professionals, as well as the effectiveness of its award-winning training and development programs, such as the business’ Clinical Foundation Program and its CRA Academy.
“Year after year, our colleagues are successful in this competition because we are dedicated to preparing and equipping our research professionals with the training and tools they need to deliver strong performance, quality and value to our customers,” said Cris Nieto, senior vice president of clinical operations, clinical research, Thermo Fisher Scientific. “This competition enables our team members to test their professional skills in a highly competitive environment, while also allowing them to demonstrate their knowledge, critical thinking and experience on a broader platform.”
The CROY Americas competition, hosted by PharmaTimes, provides clinical research professionals an opportunity to benchmark their skills against their peers through various exercises and assessments, including a three-stage competition.
In June, the PPD clinical research business was named “Clinical Research Company of the Year” at the 2022 PharmaTimes Clinical Researcher of the Year International competition in London. A number of individual PPD clinical researchers also took home top honors in the individual categories during the international competition.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Source: Nadine Maeser, Thermo Fisher Scientific, Inc.
